Myelofibrosis differential diagnosis

	Myelofibrosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Myelofibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Myelofibrosis differential diagnosis On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Myelofibrosis differential diagnosis All Images X-rays Echo and Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Myelofibrosis differential diagnosis
CDC on Myelofibrosis differential diagnosis
Myelofibrosis differential diagnosis in the news
Blogs on Myelofibrosis differential diagnosis
Directions to Hospitals Treating Myelofibrosis
Risk calculators and risk factors for Myelofibrosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Myelofibrosis must be differentiated from the following diseases:^[1]

↑ ^1.0 ^1.1 Thiele, J.; Kvasnicka, H. M.; Mullauer, L.; Buxhofer-Ausch, V.; Gisslinger, B.; Gisslinger, H. (2011). "Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification". Blood. 117 (21): 5710–5718. doi:10.1182/blood-2010-07-293761. ISSN 0006-4971.